Glycomine


Glycomine is developing orphan drugs for serious rare disorders of metabolism and protein misfolding for which no other therapeutic options exist.

Industries

Employees

11-50

Links


Org chart

Steven Axon
Director & CEO
Collapse
Hicham Alaoui
Chief Scientific Officer
Geoffrey Hird
Chief Technology Officer
Peter McWilliams
Chief Business Officer
Rose Marino
Chief Medical Officer

Board & advisors



Offices